Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.49 |
| ▸ | CTRC | Q99895 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.43 |
| ▸ | CTSG | P08311 | 3/20 | 0.43 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.43 |
| ▸ | CMA1 | P23946 | 3/20 | 0.43 |
| ▸ | F2R | P25116 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.41 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.41 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.41 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.41 |
| ▸ | IDH1 | O75874 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4593922 | 0.95 | ELANE (0.45) | ELANECTRCPTGS2PRSS1CTSG | |
| SCHEMBL6630417 | 0.88 | GAA (0.48) | ELANECTRCPTGS2PRSS1CTSG | |
| SCHEMBL4595449 | 0.85 | PRSS1 (0.43) | PTGS2PRSS1CTSGCTRB1CMA1 | |
| SCHEMBL11655496 | 0.80 | LMNA (0.57) | ELANECTRCPRSS1CTSGCTRB1 | |
| SCHEMBL6633302 | 0.80 | GAA (0.47) | LMNAHSD17B10CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL11728968 | 0.79 | GPR84 (0.40) | F2RLMNARECQLGAAXBP1 | |
| SCHEMBL11739834 | 0.79 | GPR84 (0.40) | F2RLMNARECQLGAAXBP1 | |
| SCHEMBL2542322 | 0.79 | GPR84 (0.40) | F2RLMNARECQLGAAXBP1 | |
| SCHEMBL39475 | 0.79 | GPR84 (0.40) | F2RLMNARECQLGAAXBP1 | |
| SCHEMBL8419030 | 0.79 | GPR84 (0.40) | F2RLMNARECQLGAAXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1417209-B1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORP (US) | 2008-01-16 | — | — | EP | claimed |
| EP-1417209-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | Crompton Corporation (US) | 2004-05-12 | — | — | EP | claimed |
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION, A CORPORATION OF THE STATE OF DELAWARE | 2003-04-03 | — | — | US | claimed |
| WO-2003014130-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORPORATION (US) | 2003-02-20 | — | — | WO | claimed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | claimed |
| EP-1417209-B1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORP (US) | 2008-01-16 | — | — | EP | disclosed |
| EP-1417209-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | Crompton Corporation (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION, A CORPORATION OF THE STATE OF DELAWARE | 2003-04-03 | — | — | US | disclosed |
| WO-2003014130-A1 | HIGH BOILING INHIBITORS FOR DISTILLABLE, POLYMERIZABLE MONOMERS | CROMPTON CORPORATION (US) | 2003-02-20 | — | — | WO | disclosed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065177-A1 | High boiling inhibitors for distillable, polymerizable monomers | ROS1, POLR1A, ACP1 | ELANE 2638/4885CTRC 1266/4885PTGS2 1993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.